MK0663, etoricoxib

DRUG6 trials

Sponsors

Organon and Co

Conditions

OsteoarthritisRheumatoid ArthritisRheumatoid Arthritis,Osteoarthritis

Phase 3

Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

CompletedNCT00092703

Organon and CoOsteoarthritis

Start: 2002-06-27End: 2003-11-01Target: 6000Updated: 2024-08-15

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

CompletedNCT00092768

Organon and CoOsteoarthritis

Start: 2004-03-01End: 2005-02-01Updated: 2024-08-15

Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

CompletedNCT00092742

Organon and CoRheumatoid Arthritis

Start: 2003-02-28End: 2005-12-31Updated: 2022-02-16

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

CompletedNCT00092781

Organon and CoOsteoarthritis

Start: 2004-03-01End: 2005-02-01Updated: 2024-08-15

An Investigational Drug in Patients With Osteoarthritis (0663-073)

CompletedNCT00092755

Organon and CoOsteoarthritis

Start: 2003-04-09End: 2003-11-13Updated: 2024-08-15

A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)

CompletedNCT00250445

Organon and CoRheumatoid Arthritis,Osteoarthritis

Start: 2003-01-31End: 2006-05-31Updated: 2022-02-18

Related Papers

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

2006-11-01285 citations

Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

2006-08-2780 citations